Loading clinical trials...
Loading clinical trials...
Comprehensive Analysis of Chemotherapy and Targeted Therapy Outcomes in Recurrent Malignant Gliomas: Large Single-Center Observational Cohort Study (GLIOTARG)
Conditions
Interventions
Bevacizumab-Containing Regimens
Non-Bevacizumab Regimens
+1 more
Locations
1
Russia
Blokhin's Russian Cancer Research Center
Moscow, Russia
Start Date
February 1, 2026
Primary Completion Date
October 1, 2027
Completion Date
October 1, 2027
Last Updated
March 4, 2026
NCT05969860
NCT05278208
NCT02800486
NCT05789394
NCT06934889
NCT05839379
Lead Sponsor
Blokhin's Russian Cancer Research Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions